Welcome to our dedicated page for Osi Systems SEC filings (Ticker: OSIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for OSI Systems, Inc. (NASDAQ: OSIS), a vertically integrated designer and manufacturer of specialized electronic systems and components. Through these filings, investors can review how the company reports on its Security, Optoelectronics and Manufacturing, and Healthcare divisions, as well as its capital structure and governance.
Key documents include annual reports on Form 10-K and quarterly reports on Form 10-Q, which present consolidated financial statements, segment information for Security, Optoelectronics and Manufacturing, and Healthcare, and discussions of risk factors and business operations. Earnings-related Form 8-K filings furnish press releases that summarize revenues, segment operating income, non-GAAP measures and outlook updates, such as the fiscal 2026 first quarter results.
Filings also detail capital markets and financing activities. For example, Form 8-K reports describe the issuance of 0.50% Convertible Senior Notes due 2031 under an indenture, including interest terms, maturity, conversion mechanics, redemption conditions and events of default. Other 8-K filings outline amendments to the company’s credit agreement, increases in revolving loan commitments, and the creation of direct financial obligations.
Corporate governance and executive compensation information is available in the company’s definitive proxy statement on Schedule 14A, which covers board structure, director elections, advisory votes on named executive officer compensation, and equity compensation plans. Ownership tables and Section 16-related disclosures help readers understand insider holdings and reporting compliance.
On Stock Titan, OSI Systems’ filings are supplemented with AI-powered summaries that highlight the most important points in lengthy documents such as 10-Ks, 10-Qs, proxy statements and complex 8-Ks. Real-time updates from EDGAR ensure that new filings, including Forms 4 for insider transactions when available, appear promptly, while AI-generated explanations help clarify technical terms, capital structure changes and segment-level trends for OSIS.
Deepak Chopra, Executive Chairman of OSI Systems, reported Form 4 transactions dated 08/26/2025. The filing shows the grant of 82,845 restricted stock units issued pursuant to performance-based vesting and recorded at a price of $225.19, which increased reported beneficial ownership to 414,600 shares. The filing also shows a net settlement disposition of 77,131 shares to satisfy tax withholding obligations (no shares sold), leaving 337,469 shares beneficially owned following the reported transactions. The form is signed by Mr. Chopra on 08/28/2025.
Ajay Mehra, President and CEO of OSI Systems (OSIS), reported transactions on 08/26/2025. He was issued 15,362 performance-based restricted stock units (RSUs) and, pursuant to a net settlement to cover withholding taxes, 18,850 shares were tendered (disposed). After the transactions Mr. Mehra beneficially owned 98,107 shares directly and 6,683 shares indirectly through the Mehra Family Trust, for a combined total shown on the form. The reported per-share price for the transactions was $225.19. The RSUs are described as performance-based and the Mehra Family Trust is dated 7-12-2008.
OSI Systems insider Cary M. Okawa reported a non‑derivative disposition of 84 shares of common stock on 08/22/2025. The filing shows the shares were tendered to satisfy tax withholding obligations under a net settlement and no shares were sold on the open market. After the withholding, Mr. Okawa beneficially owned 2,990 shares held directly. The report was signed on 08/25/2025 and lists his role as Chief Accounting Officer and director.
OSI Systems, Inc. presents an annual 10-K with several operational, regulatory, and financial disclosures. Management concluded internal control over financial reporting was effective as of June 30, 2025. The company maintains annual third-party cybersecurity audits and an ISO/IEC 27001 certification process. EU Medical Device Regulation changes broaden device scope and require expanded clinical evaluation and a designated compliance officer. Capital structure notes include 16,825,913 shares outstanding as of August 18, 2025 and a 2.25% convertible senior note due 2029 with a conversion price of $191.98. Concentration risk exists in the Security division receivables (one customer ~42% at June 30, 2025). The company disclosed a Department of Justice subpoena related to a former employee and reported transaction gains/(losses) of approximately $2.0M, ($5.1M), and ($12.7M) for fiscal 2023–2025. Other notable items: performance bond exposure of ~$104M, unrecognized tax benefits of $15.1M, and $12.7M of restricted stock unit compensation to be recognized over ~2.2 years.
Meyer Luskin, a director of OSI Systems Inc. (OSIS), reported a purchase of 470 shares of the issuer's common stock on 08/20/2025 at a price of $223.39 per share. After the reported acquisition, the filing shows 11,684 shares beneficially owned indirectly through the Meyer and Doreen Luskin Family Trust with Meyer and Doreen Luskin as trustees. The Form 4 also lists a disposition of 4,587 shares but does not provide a transaction date, price, or additional detail for that disposition within the visible tables. The filing is signed by Meyer Luskin on 08/22/2025.
Deepak Chopra, Executive Chairman and Director of OSI Systems, reported an insider purchase of common stock on 08/20/2025. He acquired 1,052 shares at a price of $223.39 per share, increasing his beneficial ownership to 331,755 shares. The Form 4 was signed on 08/22/2025 and identifies Chopra as the sole reporting person for this transaction.
William F. Ballhaus Jr., a director of OSI Systems, reported changes in his beneficial ownership on Form 4. On 08/20/2025 he purchased 1,007 shares of OSIS common stock at $223.39 per share and, following the transaction, beneficially owned 26,162 shares indirectly through the Ballhaus Trust. The filing also reports a disposition of 3,701 shares (reported on the same table). The Ballhaus Trust is identified as U/A 1/25/02 with William Ballhaus Jr. and Jane K. Ballhaus as trustees. The Form 4 was signed on 08/22/2025.
William F. Ballhaus Jr., a director of OSI Systems, Inc. (OSIS), reported insider transactions on Form 4 covering activity dated 08/20/2025. The filing shows an acquisition of 1,007 shares of OSIS common stock at a price of $223.39 per share, and a contemporaneous disposition of 3,701 shares. After the reported acquisition, the filing discloses beneficial ownership of 26,162 shares held indirectly through the Ballhaus Trust U/A 1/25/02, for which Dr. William Ballhaus Jr. and Jane K. Ballhaus are trustees. The Form 4 is signed by Mr. Ballhaus on 08/22/2025.
William Francis Ballhaus Jr., a director of OSI Systems, purchased 1,007 shares of OSIS common stock on 08/20/2025 at a reported price of $223.39 per share under transaction code A (acquisition). After the transaction, the filing shows beneficial ownership of 26,162 shares held indirectly through the Ballhaus Trust U/A 1/25/02 (with Dr. William Ballhaus Jr. and Jane K. Ballhaus as trustees). The filing also reports a separate disposition of 3,701 shares (no price shown). The Form 4 was signed by Mr. Ballhaus on 08/22/2025 and lists his relationship as a director.
James B. Hawkins, a director of OSI Systems, reported an open-market purchase of 895 shares of OSIS common stock on 08/20/2025 at a reported price of $223.39 per share. After the transaction he beneficially owned 6,536 shares, held directly. The Form 4 was signed on 08/22/2025 and contains no additional explanatory remarks.